Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90Angela M. Feraco,Yiwang Zhou, Ying Zheng,Lianna J. Marks,Alison Friedmann,Howard J. Weinstein,Michael P. Link,Jamie E. FlerlageBlood advances(2023)引用 0|浏览5暂无评分关键词lymphoma,low-riskAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要